ChartMill assigns a Buy % Consensus number of 83% to SXTP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-28 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-06-02 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-23 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-13 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-10-20 | HC Wainwright & Co. | Initiate | Neutral |
| 2023-10-02 | Ascendiant Capital | Initiate | Buy |
8 analysts have analysed SXTP and the average price target is 4.49 USD. This implies a price increase of 434.6% is expected in the next year compared to the current price of 0.8395.
The consensus rating for 60 DEGREES PHARMA INC (SXTP) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.